Published in

Taylor & Francis, Expert Opinion on Pharmacotherapy, 9(4), p. 1593-1603

DOI: 10.1517/eoph.4.9.1593.21050

Taylor & Francis, Expert Opinion on Pharmacotherapy, 9(4), p. 1593-1603

DOI: 10.1517/14656566.4.9.1593

Links

Tools

Export citation

Search in Google Scholar

Recurrent duodenal ulcer haemorrhage: a pharmacoeconomic comparison of various management strategies

This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background: Duodenal ulcer (DU) bleeding has a 7 – 13% mortality rate and bleeding often recurs. Prevention of recurrence is, therefore, an important goal. Eradication of Helicobacter pylori or maintenance treatment with a proton pump inhibitor (PPI) may reduce recurrent DU bleeding. Economic comparison of these options is sparse.Methods: After the control of index bleeding with endotherapy and drugs, three strategies were evaluated: empirical treatment for possible H. pylori infection followed by a PPI for 2 months; test for H. pylori, eradication if positive, maintenance PPI if negative; maintenance PPI alone. Probability and direct cost data were obtained from a Medline search and Indian hospitals, respectively. Cost-minimisation, cost-utility, one- and two-way sensitivity analyses and threshold values were evaluated. Results: Treatment of H. pylori, particularly empirical, was the preferred strategy and dominated maintenance treatment with PPI. The test-and-treat strategy was better than the empirical treatment strategy only when the probabilities of H. pylori eradication, ulcer healing following eradication and of frequency of H. pylori infection in bleeding DU were less than 58, 73 and 58%, respectively.Conclusions: Eradication of H. pylori is preferred in preventing recurrent bleeding from DU.